|
General References
American Academy of Pediatrics: Health Supervision for Children with Sickle Cell Diseases and Their Families. Pediatrics 1996; 98: 467.
Bunn, H.F. Pathogenesis and Treatment of Sickle Cell Disease. New England Journal of Medicine 1997; 337: 762-9.
Embury, S.H., Hebbel, R.P., Mohandas, N., Steinberg, M.H., eds. Sickle Cell Disease: Basic Principals and Clinical Practice. New York: Raven Press, 1994.
Platt, O.S., Branbila, D.J., Rosse, W.F., et al. Mortality in Sickle Cell Disease: Life expectancy and risk factors for early death. New England Journal of Medicine 1994; 330: 1639-44.
Serjeant, G.R., Sickle Cell Disease. Lancet 1997; 350: 725-30.
Wood, A.J., Management of Sickle Cell Disease. New England Journal of Medicine 1999; 340: 1021-1030.
Zimmerman, S., Ware, R.E., Kinney, T.R., Gaining Ground In the Fight Against Sickle Cell Disease. Contemporary Pediatrics 1997; 14: 154-177.
Internet Resource
The Sickle Cell Information Center. Atlanta: Emory University School of Medicine 1999
www.emory.edu/PEDS/SICKLE
Hydroxyurea Reference
Jayabose, S., Tugal, O., Dandoval, C., et al. Clinical and Hematological Effects of Hydroxyurea in Children With Sickle Cell Anemia. Journal of Pediatrics 1996; 129: 559-65.
Doppler Reference
Adams, R, McKie, V, Nichols, F, et al. The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease. New England Journal of Medicine 1992; 326: 605-10. |